Orca Bio
Alan Marmelstein is a Senior Scientist at Orca Bio since March 2020, following a role as a Postdoctoral Researcher at the University of California, Berkeley from January 2018 to March 2020. Prior to this, Alan completed part of doctoral research at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) as a Student Researcher from July 2015 to December 2017. Alan earned a Doctor of Philosophy (PhD) in Chemistry from Princeton University between 2012 and 2017, and a Bachelor of Science (BS) in Chemistry from Penn State University from 2008 to 2012.
This person is not in any teams
Orca Bio
3 followers
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling them to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Their talented team is driven by a passion for science and compassion for patients.